Karin Garre
Directeur/Bestuurslid bij EXPRES2ION BIOTECH HOLDING AB
Profiel
Karin Garre is an Independent Director at Expres2ion Biotech Holding AB.
She is also a Director at Cervello A.
Previously, she served as the General Manager at Symphogen A.
Before that, she was the Chief Executive Officer at K:2.
Holding ApS.
She also held the position of Chairman at NTG Nordic Transport Group A from 2013 to 2018.
Additionally, she has experience as a Director at StemCare A, StemCare Danmark A, and Lægernes Test Center A.
Dr. Garre obtained her doctorate degree from the University of Copenhagen in 1983.
Actieve functies van Karin Garre
| Bedrijven | Functie | Begin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Bestuurslid | 26-05-2021 |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 05-06-2020 |
| Cervello A/S | Directeur/Bestuurslid | - |
Eerdere bekende functies van Karin Garre
| Bedrijven | Functie | Einde |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Voorzitter | 14-09-2018 |
| Lægernes Test Center A/S | Directeur/Bestuurslid | - |
| StemCare Danmark A/S | Directeur/Bestuurslid | - |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Directeur/Bestuurslid | - |
| K:2 Holding ApS | Algemeen Directeur | - |
Opleiding van Karin Garre
| University of Copenhagen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
| K:2 Holding ApS | |
| StemCare Danmark A/S | |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Health Technology |
| Lægernes Test Center A/S | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
| Cervello A/S |
